NCT04052594View on ClinicalTrials.gov

A Study of LY3475766 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 3, 2019

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Dyslipidemias
Interventions
DRUG

LY3475766 - IV

Administered IV

DRUG

LY3475766 - SC

Administered SC

DRUG

Placebo - IV

Administered IV

DRUG

Placebo - SC

Administered SC

Trial Locations (4)

32117

Covance Clinical Research Inc, Daytona Beach

53704

Covance Clinical Research Inc, Madison

75247

Covance Dallas, Dallas

90630

WCCT Global, Cypress

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04052594 - A Study of LY3475766 in Healthy Participants | Biotech Hunter | Biotech Hunter